Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients
Authors:
- 25 February 2003
- journal article
- clinical trial
- Published by Springer Nature in Gene Therapy
- Vol. 10 (5) , 386-395
Abstract
We conducted two phase 1 trials of direct intratumoral injection of a recombinant E1E3-deleted adenovirus (AdR) encoding either the bacterial enzyme -galactosidase (Ad.RSVgal) or interleukin 2 (IL2, AdTG5327) into primary nonsmall-cell lung cancers of 21 patients. We report here virus shedding and the duration of virus expression in the tumor after intrabronchial injection of 107, 108 or 109 PFU of adenovirus. The infectious AdR and the viral DNA were detected in PBL, plasma, stool and aerodigestive samples in a dose-dependent manner, since cell cultures and PCRs were found to be positive mainly for samples from patients who received the highest AdR dose (109 PFU). We detected -galactosidase activity in the tumor biopsy samples of 66% of the patients, seemingly dose related, and only low levels of IL2 mRNA could be detected in tumor biopsy samples. E1 sequences were not detected by PCR in any of the PBL and bronchial samples collected after virus delivery, except in one patient. In this patient, E1 sequences were detected in PBL as well as in tumor biopsy samples collected at days 8, 30 and 60 and were correlated with longer -galactosidase expression in tumor samples. PBL tested before and after virus delivery contained both E1 sequences indicating that they did not result from replication-competent adenovirus (RCA) E1 sequences present in the inoculum. In addition, only on the day of the injection was Ad.RSVgal also detected in E1-positive PBL, indicating that virus replication in blood was very unlikely.Keywords
This publication has 15 references indexed in Scilit:
- Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosisLung Cancer, 2001
- The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patientsCancer, 2001
- Adenoviral-Mediated p53 Gene Transfer to Non-small Cell Lung Cancer Through Endobronchial InjectionChest, 2000
- Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 1999
- Quantitative analysis of Th1, Th2 and TGF-β1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patientsInternational Journal of Cancer, 1998
- Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.Nature Medicine, 1996
- Survival in early-stage non-small cell lung cancerThe Annals of Thoracic Surgery, 1995
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 1994
- Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.Journal of Clinical Oncology, 1992